Population Pharmacokinetics and Pharmacodynamic Target Attainment of Ampicillin in Neonates with Hypoxemic-Ischemic Encephalopathy in the Setting of Controlled Hypothermia
- PMID: 28226400
- DOI: 10.1002/phar.1916
Population Pharmacokinetics and Pharmacodynamic Target Attainment of Ampicillin in Neonates with Hypoxemic-Ischemic Encephalopathy in the Setting of Controlled Hypothermia
Abstract
Study objective: To describe the population pharmacokinetics and pharmacodynamic target attainment of ampicillin in neonates with hypoxic-ischemic encephalopathy (HIE) undergoing controlled hypothermia (CH).
Design: Prospective, open-label pharmacokinetic study.
Setting: A 189-bed, freestanding children's tertiary care teaching hospital.
Patients: Thirteen neonates (three females and 10 males) with HIE encephalopathy receiving CH and ampicillin 100 mg/kg/dose intravenously every 8 hours who were admitted to the neonatal intensive care unit between May 2013 and June 2014.
Intervention: Blood (0.5 ml) was collected at 8, 10, and 14 hours of life coinciding with other scheduled laboratory investigations for ampicillin concentration analysis, providing a total of three ampicillin serum concentrations/patient.
Measurements and main results: The patients had a median gestational age of 39 weeks, mean ± SD birth weight of 3.34 ± 0.61 kg, and mean ± SD estimated glomerular filtration rate of 43 ± 12.6 ml/minute/1.73 m2 . Ampicillin concentrations were best described by a two-compartment model with gestational age as a covariate with allometric scaling on total body clearance. The mean ± SD total body clearance for the population was 0.43 ± 0.12 ml/minute/kg (median 0.36 ml/min/kg), volume of the central compartment was 0.35 ± 0.46 L/kg, and the calculated population estimate for the total volume of distribution (Vd ) was 0.52 ± 0.28 L/kg. The R2 , bias, and precision were 0.497, 0.538, and 10.5 μg/ml and 0.972, -0.125, and 0.938 μg/ml for the observed versus population and observed versus individual predicted concentrations, respectively. Monte Carlo simulation was conducted to determine the probability of target attainment for 12 simulated ampicillin dosing regimens using 50% and 100% of the dosing interval that free drug concentration remains above the minimum inhibitory concentration (fT > MIC) in 5000 simulated neonates with HIE receiving CH. Dosing regimens of 25 and 50 mg/kg/dose every 24 hours provided for an appropriate pharmacodynamic target attainment of 50% and 100% fT > MIC.
Conclusion: To our knowledge, this study describes the first pharmacokinetic data of ampicillin in neonates with HIE receiving CH and demonstrates a reduced total body clearance and an increased Vd for ampicillin. Based on these data, modifications to the ampicillin dosing regimens seem appropriate during the period of CH. Dosing regimens of ampicillin 25 and 50 mg/kg/day were able achieve optimal probability of target attainment against all susceptible gram-negative and gram-positive bacteria in a population of neonates with HIE receiving CH for 50% and 100% fT > MIC.
Keywords: ampicillin; antibiotic dosing; hypothermia; neonatal; pharmacodynamics; pharmacokinetics.
© 2017 Pharmacotherapy Publications, Inc.
Similar articles
-
Population Pharmacokinetics of Gentamicin in Neonates with Hypoxemic-Ischemic Encephalopathy Receiving Controlled Hypothermia.Pharmacotherapy. 2018 Nov;38(11):1120-1129. doi: 10.1002/phar.2186. Epub 2018 Oct 24. Pharmacotherapy. 2018. PMID: 30300445
-
Gentamicin pharmacokinetics and dosing in neonates with hypoxic ischemic encephalopathy receiving hypothermia.Pharmacotherapy. 2013 Jul;33(7):718-26. doi: 10.1002/phar.1263. Epub 2013 Apr 1. Pharmacotherapy. 2013. PMID: 23553582 Free PMC article.
-
Population Pharmacokinetics and Pharmacodynamic Target Attainment of Vancomycin in Neonates on Extracorporeal Life Support.Pediatr Crit Care Med. 2017 Oct;18(10):977-985. doi: 10.1097/PCC.0000000000001250. Pediatr Crit Care Med. 2017. PMID: 28650363
-
Intravenous Antibiotic and Antifungal Agent Pharmacokinetic-Pharmacodynamic Dosing in Adults with Severe Burn Injury.Clin Ther. 2016 Sep;38(9):2016-31. doi: 10.1016/j.clinthera.2016.08.001. Epub 2016 Aug 30. Clin Ther. 2016. PMID: 27586127 Review.
-
Population pharmacokinetic models of first choice beta-lactam antibiotics for severe infections treatment: What antibiotic regimen to prescribe in children?J Pharm Pharm Sci. 2020;23:470-485. doi: 10.18433/jpps30927. J Pharm Pharm Sci. 2020. PMID: 33227230 Review.
Cited by
-
Pharmacokinetics of Antibiotics in Pediatric Intensive Care: Fostering Variability to Attain Precision Medicine.Antibiotics (Basel). 2021 Sep 28;10(10):1182. doi: 10.3390/antibiotics10101182. Antibiotics (Basel). 2021. PMID: 34680763 Free PMC article. Review.
-
Therapeutic Drug Monitoring Is a Feasible Tool to Personalize Drug Administration in Neonates Using New Techniques: An Overview on the Pharmacokinetics and Pharmacodynamics in Neonatal Age.Int J Mol Sci. 2020 Aug 17;21(16):5898. doi: 10.3390/ijms21165898. Int J Mol Sci. 2020. PMID: 32824472 Free PMC article. Review.
-
Pharmacokinetics during therapeutic hypothermia for neonatal hypoxic ischaemic encephalopathy: a literature review.BMJ Paediatr Open. 2020 Jun 15;4(1):e000685. doi: 10.1136/bmjpo-2020-000685. eCollection 2020. BMJ Paediatr Open. 2020. PMID: 32577535 Free PMC article. Review.
-
A Physiology-Based Pharmacokinetic Framework to Support Drug Development and Dose Precision During Therapeutic Hypothermia in Neonates.Front Pharmacol. 2020 May 13;11:587. doi: 10.3389/fphar.2020.00587. eCollection 2020. Front Pharmacol. 2020. PMID: 32477113 Free PMC article. Review.
-
Diagnostic Potential of Neural Exosome Cargo as Biomarkers for Acute Brain Injury.Ann Clin Transl Neurol. 2017 Nov 24;5(1):4-10. doi: 10.1002/acn3.499. eCollection 2018 Jan. Ann Clin Transl Neurol. 2017. PMID: 29376087 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical